BlackRock Advisors’s Cardiff Oncology CRDF Stock Holding History

BlackRock Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$31K	Hold	202	–	–	﹤0.01%	3364
2016 Q3	$65K	Hold	202	–	–	﹤0.01%	3175
2016 Q2	$66K	Buy	202 +3	+2%	+$1.03K	﹤0.01%	3146
2016 Q1	$67K	Buy	199 +20	+11%	+$6.8K	﹤0.01%	3085
2015 Q4	$70K	Sell	179 -90	-33%	-$35.2K	﹤0.01%	3077
2015 Q3	$110K	Buy	269 +35	+15%	+$18.3K	﹤0.01%	3051
2015 Q2	$171K	Buy	234 +182	+350%	+$129K	﹤0.01%	2878
2015 Q1	$26K	Hold	52	–	–	﹤0.01%	3394
2014 Q4	$16K	Buy	+52	New	+$16.8K	﹤0.01%	3548

Other funds holding CRDF

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

BlackRock Advisors's CRDF Position: Q4 2016 in Review

BlackRock Advisors held its Cardiff Oncology (CRDF) position steady in Q4 2016 at 202 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #3364.

BlackRock Advisors first reported a position in CRDF in Q4 2014 and has held it in 9 quarters since. The position peaked at $171K in Q2 2015. 68 funds tracked by Wall St. Rank hold CRDF as of Q4 2016.

BlackRock Advisors held 202 shares of Cardiff Oncology worth $31K as of Q4 2016.
BlackRock Advisors left its Cardiff Oncology share count unchanged in Q4 2016.
Cardiff Oncology made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3364 holding.
BlackRock Advisors first reported a position in Cardiff Oncology in Q4 2014 and has held it in 9 quarters since.
BlackRock Advisors's Cardiff Oncology position peaked at $171K in Q2 2015.
68 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.